Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’

Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
The EU is reportedly weighing an office of a Russia negotiator, potentially eroding Kaja Kallas’s role as the bloc’s chief diplomat...
loading...